Tower Research Capital LLC (Trc) Prometheus Biosciences, Inc. Transaction History

Tower Research Capital LLC (Trc)

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$103.46 - $126.29 $110,598 - $135,004	1,069 Added 411.15%	1,329 $143,000
Q4 2022 Feb 10, 2023	SELL	$36.06 - $117.21 $168,760 - $548,542	-4,680 Reduced 94.74%	260 $29,000
Q3 2022 Nov 10, 2022	BUY	$28.17 - $59.01 $110,088 - $230,611	3,908 Added 378.68%	4,940 $291,000
Q2 2022 Aug 15, 2022	SELL	$22.39 - $38.94 $11,889 - $20,677	-531 Reduced 33.97%	1,032 $29,000
Q1 2022 May 12, 2022	BUY	$30.13 - $50.0 $33,594 - $55,750	1,115 Added 248.88%	1,563 $59,000
Q4 2021 Feb 14, 2022	BUY	$22.28 - $39.54 $935 - $1,660	42 Added 10.34%	448 $18,000
Q3 2021 Nov 15, 2021	SELL	$20.89 - $26.96 $12,387 - $15,987	-593 Reduced 59.36%	406 $10,000
Q2 2021 Aug 16, 2021	BUY	$16.8 - $29.65 $16,783 - $29,620	999 New	999 $25,000

29.6K

Ticker RXDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,904,100
Description
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.